Announcement Exvade Bioscience is a certified neuro-oncology company known for its impeccable platform for healing the violent brain cancers has conducted a brain cancer study. The phase 1 clinical trial (study) has finally met its first patient. The trial is conducted at a well-known Academic Medi...
Announcement Arrowhead is headed to double the Tirzepatide’s weightloss in the combinational study. After proving its excellence in therapies to cure the diseases causing genes, the company has now entered the obesity area with the weight of responsibility to bring best in class solution to t...
Progress so far For many decades, there have been many challenges and a level of improvement in numerous neurodegenerative conditions. Over the past two years, uniQure’s data received a green signal for therapies shaping a new future for a subtype of amyotrophic lateral sclerosis (ALS) and Al...
Announcement TYBR Health is a known Houston-related regenerative medicine and medical technology company popular for its establishment in biomaterials therapies to refine post-operative recovery. The company has introduced the first-ever U.S. clinical use of the B3 GEL™ System. Regarding this...
Announcement GenEditBio stepped into the biotech competition in 2021 with one goal and mission in mind to serve vivo genome-editing therapeutic solutions. The company now excitedly declared that its IND (Investigational New Drug) application has received a clean chit by the U.S. Food and Drug Admin...
Announcement Novo Nordisk, the promising Danish healthcare organisation known for its excellent progress in diabetes care and later splitting its business and excellence in rare blood disorders, growth hormone therapies and obesity. The company has now launched Wegovy™ pill to be registered i...
Announcement Takeda, with a strong footprint in Europe, Japan, and the US, and popularly recognised for its Entyvio for IBD, as Asia’s third-largest pharmaceutical company, shed some light on the trial representation. Takeda raises awareness and value for its patients regarding the company&rs...
Announcement BioAtla, Inc., a leading clinical-level biotechnology company focusing on the establishment of Conditionally Active Biologic (CAB) antibody therapeutics for solid tumor treatment, has joined hands with GATC Health Corp. (GATC). GATC is a well-known tech-bio company accelerating artific...
Announcement Axsome Therapeutics, Inc., a leading biopharmaceutical company revolutionising the treatment space of central nervous system (CNS) disorders, received acceptance from the U.S. Food and Drug Administration (FDA) for its filing of the supplemental New Drug Application (NDA) for AXS-05 (b...
Announcement Intelligent Bio Solutions Inc., a leading medical technology company serving an emerging, non-invasive brilliant testing solutions, have inked a manufacturing deal with Syrma Johari MedTech Ltd. Syrma is a known well recognized medical device manufacturing and engineering company with ...
